Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial

Advances in Radiation Oncology - Tập 6 - Trang 100751 - 2021
Jacob S. Parzen1, Michael D. Chuong2, John Chang3, Lane Rosen4, James Urbanic5, William Hartsell3, Henry Tsai6, Christopher Sinesi7, Jing Zeng8, Mark Mishra9, Carlos Vargas10, Craig Stevens1, Peyman Kabolizadeh1
1Beaumont Proton Therapy Center, Department of Radiation Oncology, Oakland University William Beaumont School of Medicine, Royal Oak, Michigan
2Miami Cancer Institute, Department of Radiation Oncology, Miami, Florida
3Northwestern Medicine Chicago Proton Center, Department of Radiation Oncology, Warrenville, Illinois
4Willis-Knighton Cancer Center, Department of Radiation Oncology, Shreveport, Louisiana
5California Protons Therapy Center, Department of Radiation Oncology, San Diego, California
6Princeton ProCure Proton Therapy Center, Department of Radiation Oncology, Kendall Park, New Jersey
7Hampton University Proton Therapy Institute, Department of Radiation Oncology, Hampton, Virginia
8Seattle Cancer Care Alliance Proton Therapy Center, Department of Radiation Oncology, Seattle, Washington
9Maryland Proton Treatment Center, Department of Radiation Oncology, Baltimore, Maryland
10Mayo Clinic Proton Center, Department of Radiation Oncology, Phoenix, Arizona

Tài liệu tham khảo

Kelsen, 1998, Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer, N Engl J Med, 339, 1979, 10.1056/NEJM199812313392704

Minsky, 2002, INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: High-dose versus standard-dose radiation therapy, J Clin Oncol, 20, 1167, 10.1200/JCO.2002.20.5.1167

van Hagen, 2012, Preoperative chemoradiotherapy for esophageal or junctional cancer, N Engl J Med, 366, 2074, 10.1056/NEJMoa1112088

Davuluri, 2017, Lymphocyte nadir and esophageal cancer survival outcomes after chemoradiation therapy, Int J Radiat Oncol Biol Phys, 99, 128, 10.1016/j.ijrobp.2017.05.037

Wang, 2013, Predictors of postoperative complications after trimodality therapy for esophageal cancer, Int J Radiat Oncol Biol Phys, 86, 885, 10.1016/j.ijrobp.2013.04.006

Chandra, 2005, Feasibility of using intensity-modulated radiotherapy to improve lung sparing in treatment planning for distal esophageal cancer, Radiother Oncol, 77, 247, 10.1016/j.radonc.2005.10.017

Kole, 2012, Comparison of heart and coronary artery doses associated with intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for distal esophageal cancer, Int J Radiat Oncol Biol Phys, 83, 1580, 10.1016/j.ijrobp.2011.10.053

Lin, 2012, Propensity score-based comparison of long-term outcomes with 3-dimensional conformal radiotherapy vs intensity-modulated radiotherapy for esophageal cancer, Int J Radiat Oncol Biol Phys, 84, 1078, 10.1016/j.ijrobp.2012.02.015

Chuong, 2016, Improving outcomes for esophageal cancer using proton beam therapy, Int J Radiat Oncol Biol Phys, 95, 488, 10.1016/j.ijrobp.2015.11.043

Newhauser, 2015, The physics of proton therapy, Phys Med Biol, 60, R155, 10.1088/0031-9155/60/8/R155

Lin, 2017, Multi-institutional analysis of radiation modality use and postoperative outcomes of neoadjuvant chemoradiation for esophageal cancer, Radiother Oncol, 123, 376, 10.1016/j.radonc.2017.04.013

Xi, 2017, Comparative outcomes after definitive chemoradiotherapy using proton beam therapy versus intensity modulated radiation therapy for esophageal cancer: A retrospective, single-institutional analysis, Int J Radiat Oncol Biol Phys, 99, 667, 10.1016/j.ijrobp.2017.06.2450

Hirano, 2018, Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced esophageal squamous cell carcinoma, Radiat Oncol, 13, 23, 10.1186/s13014-018-0966-5

Lin, 2020, Randomized phase IIB trial of proton beam therapy versus intensity-modulated radiation therapy for locally advanced esophageal cancer, J Clin Oncol

Lin, 2012, Proton beam therapy and concurrent chemotherapy for esophageal cancer, Int J Radiat Oncol Biol Phys, 83, e345, 10.1016/j.ijrobp.2012.01.003

Jethwa, 2020, The emerging role of proton therapy for esophagus cancer, J Gastrointest Oncol, 11, 144, 10.21037/jgo.2019.11.04

Nakamura, 1990, Radiosensitivity of CD4 or CD8 positive human T-lymphocytes by an in vitro colony formation assay, Radiat Res, 123, 224, 10.2307/3577549

Hung, 1998, The central role of CD4(+) T cells in the antitumor immune response, J Exp Med, 188, 2357, 10.1084/jem.188.12.2357

Geh, 2006, Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: Evidence of a radiation and chemotherapy dose response, Radiother Oncol, 78, 236, 10.1016/j.radonc.2006.01.009

Hulshof, 2020, A randomized controlled phase III multicenter study on dose escalation in definitive chemoradiation for patients with locally advanced esophageal cancer: ARTDECO study, J Clini Oncol, 38, 281, 10.1200/JCO.2020.38.4_suppl.281

Patel, 1998, Biomechanical and sensory parameters of the human esophagus at four levels, Am J Physiol, 275, G187

Krarup, 2011, Proximal and distal esophageal sensitivity is decreased in patients with Barrett's esophagus, World J Gastroenterol, 17, 514, 10.3748/wjg.v17.i4.514

Thông tin
Thông tin xuất bản

Advances in Radiation Oncology

Tập 6

100751

Thông tin tác giả